Galactosylated pullulan-curcumin conjugate micelles for site specific anticancer activity to hepatocarcinoma cells

Colloids and Surfaces B: Biointerfaces

Volumn 133, Issue , 2015, Pages 347-355

  Sarika, P R ^a   James, Nirmala Rachel ^a   Nishna, N ^b   Anil Kumar, P R ^c   Raj, Deepa K ^c  

^a INDIAN INSTITUTE OF SPACE SCIENCE AND TECHNOLOGY   (India)

^b INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH BHOPAL   (India)

^c SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

Author keywords

Curcumin; Micelle; Polymer drug conjugate; Pullulan; Self assembly

Indexed keywords

CYTOLOGY; MICELLES; MOLECULAR BIOLOGY; PH; SELF ASSEMBLY;

ANTICANCER ACTIVITIES; ASIALOGLYCOPROTEIN RECEPTORS; CURCUMIN; HYDRODYNAMIC DIAMETER; POLYMER DRUGS; PULLULANS; SPHERICAL MORPHOLOGIES; SYNTHETIC STRATEGIES;

CELLS;

ASIALOGLYCOPROTEIN RECEPTOR; CURCUMIN; DOXORUBICIN; LACTOBIONIC ACID; POLYMER; PULLULAN; ANTINEOPLASTIC AGENT; GALACTOSE; GLUCAN; MICELLE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CRITICAL MICELLE CONCENTRATION; DRUG CONJUGATION; DRUG CYTOTOXICITY; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENDOCYTOSIS; GEL PERMEATION CHROMATOGRAPHY; HEPATOCELLULAR CARCINOMA CELL LINE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYDRODYNAMICS; HYDROPHILICITY; IN VITRO STUDY; INFRARED SPECTROSCOPY; INTERNALIZATION; MICELLE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ROOM TEMPERATURE; CHEMISTRY; HEPG2 CELL LINE; LIVER TUMOR; PATHOLOGY; SCANNING ELECTRON MICROSCOPY;

ANTINEOPLASTIC AGENTS; CURCUMIN; DRUG STABILITY; GALACTOSE; GLUCANS; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE SPECTROSCOPY; MICELLES; MICROSCOPY, ELECTRON, SCANNING;

EID: 84933047832     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2015.06.020     Document Type: Article

References (44)

1. Aggarwal B.B., Surh Y.-J., Shishodia S. The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease 2007, Springer.
2. Maheshwari R.K., Singh A.K., Gaddipati J., Srimal R.C. Multiple biological activities of curcumin: a short review. Life Sci. 2006, 78:2081-2087.
3. Anand P., Kunnumakkara A.B., Newman R.A., Aggarwal B.B. Bioavailability of curcumin: problems and promises. Mol. Pharm. 2007, 4:807-818.
4. Joe B., Vijaykumar M., Lokesh B. Biological properties of curcumin-cellular and molecular mechanisms of action. Crit. Rev. Food Sci. Nutr. 2004, 44:97-111.
5. Goel A., Boland C.R., Chauhan D.P. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells. Cancer Lett. 2001, 172:111-118.
6. Kim J.H., Li Y., Kim M.S., Kang S.W., Jeong J.H., Lee D.S. Synthesis and evaluation of biotin-conjugated pH-responsive polymeric micelles as drug carriers. Int. J. Pharm. 2012, 427:435-442.
7. Chacko R.T., Ventura J., Zhuang J., Thayumanavan S. Polymer nanogels: a versatile nanoscopic drug delivery platform. Adv. Drug Deliv. Rev. 2012, 64:836-851.
8. Yang X., Chen L., Han B., Yang X., Duan H. Preparation of magnetite and tumor dual-targeting hollow polymer microspheres with pH-sensitivity for anticancer drug-carriers. Polymer 2010, 51:2533-2539.
9. Salmaso S., Semenzato A., Caliceti P., Hoebeke J., Sonvico F., Dubernet C., Couvreur P. Specific antitumor targetable β-cyclodextrin-poly (ethylene glycol)-folic acid drug delivery bioconjugate. Bioconjug. Chem. 2004, 15:997-1004.
10. Salmaso S., Bersani S., Semenzato A., Caliceti P. New cyclodextrin bioconjugates for active tumour targeting. J. Drug Target. 2007, 15:379-390.
11. Caldorera-Moore M., Guimard N., Shi L., Roy K. Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers. Expert Opin. Drug Deliv. 2010, 7:479-495.
12. Zhan F., Chen W., Wang Z., Lu W., Cheng R., Deng C., Meng F., Liu H., Zhong Z. Acid-activatable prodrug nanogels for efficient intracellular doxorubicin release. Biomacromolecules 2011, 12:3612-3620.
13. Xiao H., Qi R., Liu S., Hu X., Duan T., Zheng Y., Huang Y., Jing X. Biodegradable polymer-cisplatin (IV) conjugate as a pro-drug of cisplatin (II). Biomaterials 2011, 32:7732-7739.
14. Yang W.-Z., Chen H.-L., Gao F.-P., Chen M.-M., Li X.-M., Zhang M.-M., Zhang Q.-Q., Liu L.-R., Jiang Q., Wang Y.-S. Self-aggregated nanoparticles of cholesterol-modified pullulan conjugate as a novel carrier of mitoxantronep. Curr. Nanosci. 2010, 6:298-306.
15. San Juan A., Hlawaty H., Chaubet F., Letourneur D., Feldman L.J. Cationized pullulan 3D matrices as new materials for gene transfer. J. Biomed. Mater. Res. A 2007, 82:354-362.
16. Zhang H., Li F., Yi J., Gu C., Fan L., Qiao Y., Tao Y., Cheng C., Wu H. Folate-decorated maleilated pullulan-doxorubicin conjugate for active tumor-targeted drug delivery. Eur. J. Pharm. Sci. 2011, 42:517-526.
17. Na K., Lee K.H., Bae Y.H. pH-sensitivity and pH-dependent interior structural change of self-assembled hydrogel nanoparticles of pullulan acetate/oligo-sulfonamide conjugate. J. Control. Release 2004, 97:513-525.
18. Akiyoshi K., Kobayashi S., Shichibe S., Mix D., Baudys M., Wan Kim S., Sunamoto J. Self-assembled hydrogel nanoparticle of cholesterol-bearing pullulan as a carrier of protein drugs: complexation and stabilization of insulin. J. Control. Release 1998, 54:313-320.
19. Na K., Bae Y.H. Self-assembled hydrogel nanoparticles responsive to tumor extracellular pH from pullulan derivative/sulfonamide conjugate: characterization, aggregation, and adriamycin release in vitro. Pharm. Res. 2002, 19:681-688.
20. Hirakura T., Nomura Y., Aoyama Y., Akiyoshi K. Photoresponsive nanogels formed by the self-assembly of spiropyrane-bearing pullulan that act as artificial molecular chaperones. Biomacromolecules 2004, 5:1804-1809.
21. Bonzi G., Salmaso S., Scomparin A., Eldar-Boock A., Satchi-Fainaro R., Caliceti P. A novel pullulan bioconjugate for selective breast cancer bone metastases treatment. Bioconjug. Chem. 2015.
22. Scomparin A., Salmaso S., Bersani S., Satchi-Fainaro R., Caliceti P. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery. Eur. J. Pharm. Sci. 2011, 42:547-558.
23. Cavallaro G., Maniscalco L., Caliceti P., Salmaso S., Semenzato A., Giammona G. Glycosilated macromolecular conjugates of antiviral drugs with a polyaspartamide. J. Drug Target. 2004, 12:593-605.
24. Bruneel D., Schacht E. Chemical modification of pullulan: 1. Periodate oxidation. Polymer 1993, 34:2628-2632.
25. Yang R., Zhang S., Kong D., Gao X., Zhao Y., Wang Z. Biodegradable polymer-curcumin conjugate micelles enhance the loading and delivery of low-potency curcumin. Pharm. Res. 2012, 29:3512-3525.
26. Guo H., Zhang D., Li C., Jia L., Liu G., Hao L., Zheng D., Shen J., Li T., Guo Y. Self-assembled nanoparticles based on galactosylated O-carboxymethyl chitosan-graft-stearic acid conjugates for delivery of doxorubicin. Int. J. Pharm. 2013, 458:31-38.
27. Lu D., Wen X., Liang J., Gu Z., Zhang X., Fan Y. A pH-sensitive nano drug delivery system derived from pullulan/doxorubicin conjugate. J. Biomed. Mater. Res. B Appl. Biomater. 2009, 89:177-183.
28. Tao Y., He J., Zhang M., Hao Y., Liu J., Ni P. Galactosylated biodegradable poly ((-caprolactone-co-phosphoester) random copolymer nanoparticles for potent hepatoma-targeting delivery of doxorubicin. Polym. Chem. 2014, 5:3443-3452.
29. Zheng D., Duan C., Zhang D., Jia L., Liu G., Liu Y., Wang F., Li C., Guo H., Zhang Q. Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin. Int. J. Pharm. 2012, 436:379-386.
30. Zhou N., Zan X., Wang Z., Wu H., Yin D., Liao C., Wan Y. Galactosylated chitosan-polycaprolactone nanoparticles for hepatocyte-targeted delivery of curcumin. Carbohydr. Polym. 2013, 94:420-429.
31. Haensler J., Schuber F. Preparation of neo-galactosylated liposomes and their interaction with mouse peritoneal macrophages. Biochim. Biophys. Acta 1988, 946:95-105.
32. Zhang M., Zhou X., Wang B., Yung B.C., Lee L.J., Ghoshal K., Lee R.J. Lactosylated gramicidin-based lipid nanoparticles (Lac-GLN) for targeted delivery of anti-miR-155 to hepatocellular carcinoma. J. Control. release 2013, 168:251-261.
33. Hayashi Y., Mori Y., Yamashita S., Motoyama K., Higashi T., Jono H., Ando Y., Arima H. Potential use of lactosylated dendrimer (G3)/α-cyclodextrin conjugates as hepatocyte-specific sirna carriers for the treatment of familial amyloidotic polyneuropathy. Mol. Pharm. 2012, 9:1645-1653.
34. Li Y., Huang G., Diakur J., Wiebe L.I. Targeted delivery of macromolecular drugs: asialoglycoprotein receptor (ASGPR) expression by selected hepatoma cell lines used in antiviral drug development. Curr. Drug Deliv. 2008, 5:299-302.
35. Lee S.H., Mok H., Lee Y., Park T.G. Self-assembled siRNA-PLGA conjugate micelles for gene silencing. J. Control. Release 2011, 152:152-158.
36. Endres T.K., Beck-Broichsitter M., Samsonova O., Renette T., Kissel T.H. Self-assembled biodegradable amphiphilic PEG-PCL-lPEI triblock copolymers at the borderline between micelles and nanoparticles designed for drug and gene delivery. Biomaterials 2011, 32:7721-7731.
37. Yinsong W., Lingrong L., Jian W., Zhang Q. Preparation and characterization of self-aggregated nanoparticles of cholesterol-modified O-carboxymethyl chitosan conjugates. Carbohydr. Polym. 2007, 69:597-606.
38. Yu C., Gao C., Lü S., Chen C., Huang Y., Liu M. Redox-responsive shell-sheddable micelles self-assembled from amphiphilic chondroitin sulfate-cholesterol conjugates for triggered intracellular drug release. Chem. Eng. J. 2013, 228:290-299.
39. Manju S., Sreenivasan K. Conjugation of curcumin onto hyaluronic acid enhances its aqueous solubility and stability. J. Colloid Interface Sci. 2011, 359:318-325.
40. Thomsen L.B., Lichota J., Kim K.S., Moos T. Gene delivery by pullulan derivatives in brain capillary endothelial cells for protein secretion. J. Control. Release 2011, 151:45-50.
41. Wichitnithad W., Nimmannit U., Callery P.S., Rojsitthisak P. Effects of different carboxylic ester spacers on chemical stability, release characteristics, and anticancer activity of mono-PEGylated curcumin conjugates. J. Pharm. Sci. 2011, 100:5206-5218.
42. Xin Y., Yuan J. Schiff's base as a stimuli-responsive linker in polymer chemistry. Polym. Chem. 2012, 3:3045-3055.
43. Yang R., Meng F., Ma S., Huang F., Liu H., Zhong Z. Galactose-decorated cross-linked biodegradable poly (ethylene glycol)-b-poly ((-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel. Biomacromolecules 2011, 12:3047-3055.
44. Craparo E.F., Triolo D., Pitarresi G., Giammona G., Cavallaro G. Galactosylated micelles for a ribavirin prodrug targeting to hepatocytes. Biomacromolecules 2013, 14:1838-1849.